You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

List of Excipients in API cyanocobalamin


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing cyanocobalamin

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
ENDO USA Inc NASCOBAL cyanocobalamin 49884-270 BENZALKONIUM CHLORIDE
ENDO USA Inc NASCOBAL cyanocobalamin 49884-270 CITRIC ACID MONOHYDRATE
ENDO USA Inc NASCOBAL cyanocobalamin 49884-270 GLYCERIN
ENDO USA Inc NASCOBAL cyanocobalamin 49884-270 SODIUM CITRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing cyanocobalamin

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc cyanocobalamin 0143-9621 BENZYL ALCOHOL
Hikma Pharmaceuticals USA Inc cyanocobalamin 0143-9621 SODIUM CHLORIDE
Hikma Pharmaceuticals USA Inc cyanocobalamin 0143-9621 WATER
Henry Schein Inc cyanocobalamin 0404-9783 BENZYL ALCOHOL
Henry Schein Inc cyanocobalamin 0404-9783 HYDROCHLORIC ACID
Henry Schein Inc cyanocobalamin 0404-9783 SODIUM CHLORIDE
Henry Schein Inc cyanocobalamin 0404-9783 SODIUM HYDROXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for cyanocobalamin

Excipient focus: ACETIC ACID

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: BENZYL ALCOHOL

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

cyanocobalamin drug variants not containing HYDROCHLORIC ACID

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc cyanocobalamin 0143-9621
Henry Schein Inc cyanocobalamin 0404-9786
American Regent Inc cyanocobalamin 0517-0031
Accord Healthcare Inc cyanocobalamin 16729-533
Lupin PharmaceuticalsInc cyanocobalamin 43386-237
Padagis Israel Pharmaceuticals Ltd cyanocobalamin 45802-491
ENDO USA Inc cyanocobalamin 49884-270
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

cyanocobalamin drug variants not containing SODIUM HYDROXIDE

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc cyanocobalamin 0143-9621
Henry Schein Inc cyanocobalamin 0404-9786
American Regent Inc cyanocobalamin 0517-0031
Accord Healthcare Inc cyanocobalamin 16729-533
Lupin PharmaceuticalsInc cyanocobalamin 43386-237
Padagis Israel Pharmaceuticals Ltd cyanocobalamin 45802-491
ENDO USA Inc cyanocobalamin 49884-270
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

cyanocobalamin drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc cyanocobalamin 0143-9621
Henry Schein Inc cyanocobalamin 0404-9783
Henry Schein Inc cyanocobalamin 0404-9786
Henry Schein Inc cyanocobalamin 0404-9840
American Regent Inc cyanocobalamin 0517-0031
Accord Healthcare Inc cyanocobalamin 16729-533
Sagent Pharmaceuticals cyanocobalamin 25021-502
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links